BindingDB logo
myBDB logout

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23688699 3 Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists.EBI University of Camerino
16250663 8 Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.EBI University of Bonn
20045645 66 Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.EBI Roche Palo Alto
22370269 44 Discovery of P2X3 selective antagonists for the treatment of chronic pain.EBI AstraZeneca
21207957 163 Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.EBI University of Bonn
12213051 207 Purine and pyrimidine (P2) receptors as drug targets.EBI National Institute of Diabetes
19231180 81 Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.EBI Roche Palo Alto LLC
19231178 61 Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.EBI Roche Palo Alto LLC
11462975 50 Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.EBI National Institute of Diabetes and Digestive and Kidney Diseases
9632352 7 A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.EBI National Institute of Diabetes and Digestive and Kidney Diseases
11111828 16 Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.BDB Biocentre Niederursel